Stocks / Biotech
PCVXBiotech
Vaxcyte, Inc.
$60.361d -1.3%5d -0.6%settled close · 2026-09-08
Mkt cap $7.9B (9/8)β 0.9552w $31–63Shares 143.9MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2020Emp. 507HQ San Carlos, CAvaxcyte.com
Who’s talkingIdea Scout · free
Who’s talking about PCVX
No tracked investor commentary on PCVX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026
Confirmed date · consensus EPS -2.18. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where PCVX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 23 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-01 | ||||||
| 2026-08-24 | ||||||
| 2026-08-21 | ||||||
| 2026-08-19 | ||||||
| 2026-08-18 | ||||||
| 2026-08-04 | ||||||
| 2026-06-29 | ||||||
| 2026-05-15 | ||||||
| 2026-05-14 | ||||||
| 2026-05-13 | ||||||
| 2026-05-12 | ||||||
| 2026-05-11 | ||||||
| 2026-04-24 | ||||||
| 2026-04-21 | ||||||
| 2026-04-17 | ||||||
| 2026-04-16 | ||||||
| 2026-04-15 | ||||||
| 2026-04-14 | ||||||
| 2026-04-01 | ||||||
| 2026-03-30 | ||||||
| 2026-03-25 | ||||||
| 2026-03-18 | ||||||
| 2026-03-16 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
PCVX is in this morning’s Brief.
Get The Brief — $20/mo →